A Merck subsidiary with facilities in Little Falls announced an agreement to acquire a Morristown-based technology support services company Tuesday, intending to take its pharmaceutical business to the international stage.
Telerx, which provides U.S. customer care services, says its deal for C3i is expected to close in the second quarter of 2014. Terms were not disclosed.
“Telerx is focused in the U.S., and this allows us to expand globally,” said Linda Schellenger, president of Telerx. “This will really be a combination of the two companies, allowing us to sell the current product line in the U.S. to other markets.”
C3i, which focuses on the life sciences industry, has 1,500 employees globally and does business with more than 50 percent of the world’s largest pharmaceutical companies, according to Telerx.
“We have not made any announcements or decisions to change anything from business as usual for both companies,” Schellenger said.
Telerx is headquartered in Horsham, Pa., with additional contact centers in Allentown and Wilkes-Barre, Pa.; El Paso, Texas; Kings Mountain, N.C.; and Little Falls, N.J.
C3i is based in Morristown, with global operations in North America, Europe, India and China.
“Together, C3i and Telerx will have an opportunity to take our existing services to the next level and meet the growing global demand for sophisticated solutions to complex health-care processes,” said Joel H. Morse, chief executive and co-founder of C3i.
ALSO ON NJBIZ: